BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29649328)

  • 1. Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
    Saito H; Hirayama A; Umemura T; Joshita S; Mukawa K; Suga T; Tanaka E; Ota M
    PLoS One; 2018; 13(4):e0195778. PubMed ID: 29649328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis.
    Wilson TJ; Jobim M; Jobim LF; Portela P; Salim PH; Rosito MA; Damin DC; Flores C; Peres A; Machado MB; Chies JA; Schwartsmann G; Roesler R
    Hum Immunol; 2010 Mar; 71(3):293-7. PubMed ID: 20036705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
    Okada Y; Yamazaki K; Umeno J; Takahashi A; Kumasaka N; Ashikawa K; Aoi T; Takazoe M; Matsui T; Hirano A; Matsumoto T; Kamatani N; Nakamura Y; Yamamoto K; Kubo M
    Gastroenterology; 2011 Sep; 141(3):864-871.e1-5. PubMed ID: 21699788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
    Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.
    Jones DC; Edgar RS; Ahmad T; Cummings JR; Jewell DP; Trowsdale J; Young NT
    Genes Immun; 2006 Oct; 7(7):576-82. PubMed ID: 16929347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
    Nozawa Y; Umemura T; Joshita S; Katsuyama Y; Shibata S; Kimura T; Morita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
    PLoS One; 2013; 8(12):e83381. PubMed ID: 24349500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQ: Celiac disease
    Bosca-Watts MM; Minguez M; Planelles D; Navarro S; Rodriguez A; Santiago J; Tosca J; Mora F
    World J Gastroenterol; 2018 Jan; 24(1):96-103. PubMed ID: 29358886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.
    López-Hernández R; Campillo JA; Legaz I; Valdés M; Salama H; Boix F; Hernández-Martínez AM; Eguia J; González-Martínez G; Moya-Quiles MR; Minguela A; García-Alonso A; Carballo F; Muro M
    Microbiol Immunol; 2016 Nov; 60(11):787-792. PubMed ID: 27797112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis.
    Fathollahi A; Aslani S; Mostafaei S; Rezaei N; Mahmoudi M
    Inflamm Res; 2018 Sep; 67(9):727-736. PubMed ID: 29869094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.